Innospec | IOSP - Current Liabilities


Innospec reported $334.8M in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Akzo Nobel EUR 4.39B 180M Mar/2026
Arkema EUR 2.15B 108.8M Mar/2026
Arq USD 45.08M 2.78M Mar/2026
Ashland USD 395M 29M Mar/2026
Avient USD 803.1M 43.2M Mar/2026
Balchem USD 152.54M 23.84M Mar/2026
BASF EUR 16.41B 838M Dec/2025
Croda International GBP 547.7M 209.7M Dec/2024
Evogene USD 3.44M 636K Dec/2025
Flotek Industries USD 68.73M 12.25M Mar/2026
FutureFuel USD 17.74M 7.58M Dec/2025
HB Fuller USD 743.36M 69.13M Sep/2025
Huntsman USD 1.72B 130M Mar/2026
Innospec USD 334.8M 25.3M Mar/2026
Minerals Technologies USD 543.4M 12M Mar/2026
NewMarket USD 417.26M 2.02M Mar/2026
Quaker Chemical USD 388.5M 8.34M Mar/2026
Rayonier Advanced Materials USD 385.21M 24.83M Mar/2026
Sensient Technologies USD 223.71M 39.87M Mar/2026
Solvay EUR 1.79B 59M Mar/2026
Stepan USD 720.45M 53.96M Mar/2026
Total Nigeria NGN 295.67B 80.96B Mar/2026
Valhi USD 386M 63.3M Mar/2026